dc.contributor.author
Petutschnigg, Johannes
dc.contributor.author
Ferreira, João Pedro
dc.contributor.author
Holzendorf, Volker
dc.contributor.author
Trippel, Tobias D.
dc.contributor.author
Hashemi, Djawid
dc.contributor.author
Wachter, Rolf
dc.contributor.author
Herrmann‐Lingen, Christoph
dc.contributor.author
Hasenfuß, Gerd
dc.contributor.author
Zannad, Faiez
dc.contributor.author
Pieske, Burkert
dc.contributor.author
Edelmann, Frank
dc.date.accessioned
2022-02-01T14:39:25Z
dc.date.available
2022-02-01T14:39:25Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/33837
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-33556
dc.rights.uri
https://creativecommons.org/licenses/by-nc/4.0/
dc.subject
Adipose Tissue
en
dc.subject
Heart Failure
en
dc.subject
Mineralocorticoid Receptor Antagonists
en
dc.subject
Spironolactone
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1002/ejhf.1723
dcterms.bibliographicCitation.journaltitle
European Journal of Heart Failure
dcterms.bibliographicCitation.number
3
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
559
dcterms.bibliographicCitation.pageend
561
dcterms.bibliographicCitation.volume
22
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31912594
dcterms.isPartOf.issn
1388-9842
dcterms.isPartOf.eissn
1879-0844
